Longboard Pharmaceuticals (LBPH) EBITDA (2021 - 2024)
Longboard Pharmaceuticals (LBPH) EBITDA from Mar 31, 2021 to Sep 30, 2024. The TTM Longboard Pharmaceuticals (LBPH) EBITDA is -$88M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Longboard Pharmaceuticals (LBPH) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +65.44% |
| 3 Years TTM | +66.26% |
| All Time TTM | +49.94% |
Annual EBITDA change of Longboard Pharmaceuticals (LBPH)
| Year | EBITDA | Change |
|---|---|---|
| 2024 | -$72M | +26.72% |
| 2023 | -$57M | +26.89% |
| 2022 | -$45M | +60.73% |
| 2021 | -$28M | N/A |